RDD Pharma, a developer of intra-anal drug delivery devices that deliver a drug to the anal canal, has raised $7.15 million in a financing round led by OrbiMed Advisors LLC. RDD Pharma was founded in 2009 at the Ofakim Hi-Tech Ventures incubator and is based in Ofakim, Israel. The company also develops a drug for the treatment spinal cord injury related fecal incontinence. RDD Pharma completed a proof of concept trial in healthy subjects in Israel and met with the FDA on the protocols for further clinical trials.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

EU Awards $5M To Greenhouse Solar Panel Project
February 07, 2023

Israel Builds Super-Advanced Children’s Hospital
February 07, 2023

Two Thirds Of Hi-Tech Workers In Israel Are Men, Study Finds
February 06, 2023

Ancient Crop Is Gene-Edited For Modern Farms
February 06, 2023
Facebook comments